Similarly to stomach cancer, we divided colorectal cancer by anatomical location (left versus right colon) and also based on the presence of MSI and POLE hypermutation, which have therapeutic relevance, yielding AUCs of 0.61 to 0.99 (Fig 2B). This evidence concerns the gene POLE and gastric cancer.